Open Access
Open access
Molecular Cancer, volume 16, issue 1, publication number 79

ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway

Zhao Yang 1
HU XINGBIN 1
Liu Yajing 1
Dong Shumin 1
Wen Zhaowei 1
He Wanming 1
Zhang Shuyi 1
Huang Qiong 1
Shi Min 1
Publication typeJournal Article
Publication date2017-04-13
Journal: Molecular Cancer
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor37.3
ISSN14764598
Cancer Research
Oncology
Molecular Medicine
Abstract
Cancer cells are frequently confronted with metabolic stress in tumor microenvironments due to their rapid growth and limited nutrient supply. Metabolic stress induces cell death through ROS-induced apoptosis. However, cancer cells can adapt to it by altering the metabolic pathways. AMPK and AKT are two primary effectors in response to metabolic stress: AMPK acts as an energy-sensing factor which rewires metabolism and maintains redox balance. AKT broadly promotes energy production in the nutrient abundance milieu, but the role of AKT under metabolic stress is in dispute. Recent studies show that AMPK and AKT display antagonistic roles under metabolic stress. Metabolic stress-induced ROS signaling lies in the hub between metabolic reprogramming and redox homeostasis. Here, we highlight the cross-talk between AMPK and AKT and their regulation on ROS production and elimination, which summarizes the mechanism of cancer cell adaptability under ROS stress and suggests potential options for cancer therapeutics.

Citations by journals

2
4
6
8
10
12
14
16
18
20
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 19, 4.46%
International Journal of Molecular Sciences
19 publications, 4.46%
Cancers
Cancers, 11, 2.58%
Cancers
11 publications, 2.58%
Frontiers in Pharmacology
Frontiers in Pharmacology, 11, 2.58%
Frontiers in Pharmacology
11 publications, 2.58%
Frontiers in Immunology
Frontiers in Immunology, 9, 2.11%
Frontiers in Immunology
9 publications, 2.11%
Oxidative Medicine and Cellular Longevity
Oxidative Medicine and Cellular Longevity, 8, 1.88%
Oxidative Medicine and Cellular Longevity
8 publications, 1.88%
Cells
Cells, 8, 1.88%
Cells
8 publications, 1.88%
Molecules
Molecules, 7, 1.64%
Molecules
7 publications, 1.64%
Antioxidants
Antioxidants, 7, 1.64%
Antioxidants
7 publications, 1.64%
Biomedicine and Pharmacotherapy
Biomedicine and Pharmacotherapy, 7, 1.64%
Biomedicine and Pharmacotherapy
7 publications, 1.64%
Frontiers in Oncology
Frontiers in Oncology, 6, 1.41%
Frontiers in Oncology
6 publications, 1.41%
Cell Death and Disease
Cell Death and Disease, 6, 1.41%
Cell Death and Disease
6 publications, 1.41%
Journal of Experimental and Clinical Cancer Research
Journal of Experimental and Clinical Cancer Research, 5, 1.17%
Journal of Experimental and Clinical Cancer Research
5 publications, 1.17%
Cell Death Discovery
Cell Death Discovery, 5, 1.17%
Cell Death Discovery
5 publications, 1.17%
Pharmacological Research
Pharmacological Research, 5, 1.17%
Pharmacological Research
5 publications, 1.17%
Life Sciences
Life Sciences, 5, 1.17%
Life Sciences
5 publications, 1.17%
Redox Biology
Redox Biology, 5, 1.17%
Redox Biology
5 publications, 1.17%
Frontiers in Cell and Developmental Biology
Frontiers in Cell and Developmental Biology, 4, 0.94%
Frontiers in Cell and Developmental Biology
4 publications, 0.94%
Biomolecules
Biomolecules, 4, 0.94%
Biomolecules
4 publications, 0.94%
Life
Life, 4, 0.94%
Life
4 publications, 0.94%
Cancer Letters
Cancer Letters, 3, 0.7%
Cancer Letters
3 publications, 0.7%
Antioxidants and Redox Signaling
Antioxidants and Redox Signaling, 3, 0.7%
Antioxidants and Redox Signaling
3 publications, 0.7%
Pharmaceuticals
Pharmaceuticals, 3, 0.7%
Pharmaceuticals
3 publications, 0.7%
Frontiers in Neuroscience
Frontiers in Neuroscience, 3, 0.7%
Frontiers in Neuroscience
3 publications, 0.7%
Molecular Cancer
Molecular Cancer, 3, 0.7%
Molecular Cancer
3 publications, 0.7%
Scientific Reports
Scientific Reports, 3, 0.7%
Scientific Reports
3 publications, 0.7%
Journal of Translational Medicine
Journal of Translational Medicine, 3, 0.7%
Journal of Translational Medicine
3 publications, 0.7%
PLoS ONE
PLoS ONE, 3, 0.7%
PLoS ONE
3 publications, 0.7%
Free Radical Biology and Medicine
Free Radical Biology and Medicine, 3, 0.7%
Free Radical Biology and Medicine
3 publications, 0.7%
Environmental Toxicology
Environmental Toxicology, 3, 0.7%
Environmental Toxicology
3 publications, 0.7%
2
4
6
8
10
12
14
16
18
20

Citations by publishers

10
20
30
40
50
60
70
80
90
Elsevier
Elsevier, 89, 20.89%
Elsevier
89 publications, 20.89%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 78, 18.31%
Multidisciplinary Digital Publishing Institute (MDPI)
78 publications, 18.31%
Springer Nature
Springer Nature, 71, 16.67%
Springer Nature
71 publications, 16.67%
Frontiers Media S.A.
Frontiers Media S.A., 42, 9.86%
Frontiers Media S.A.
42 publications, 9.86%
Wiley
Wiley, 29, 6.81%
Wiley
29 publications, 6.81%
Hindawi Limited
Hindawi Limited, 13, 3.05%
Hindawi Limited
13 publications, 3.05%
Taylor & Francis
Taylor & Francis, 12, 2.82%
Taylor & Francis
12 publications, 2.82%
American Chemical Society (ACS)
American Chemical Society (ACS), 10, 2.35%
American Chemical Society (ACS)
10 publications, 2.35%
Mary Ann Liebert
Mary Ann Liebert, 5, 1.17%
Mary Ann Liebert
5 publications, 1.17%
Spandidos Publications
Spandidos Publications, 4, 0.94%
Spandidos Publications
4 publications, 0.94%
Oxford University Press
Oxford University Press, 4, 0.94%
Oxford University Press
4 publications, 0.94%
Royal Society of Chemistry (RSC)
Royal Society of Chemistry (RSC), 4, 0.94%
Royal Society of Chemistry (RSC)
4 publications, 0.94%
SAGE
SAGE, 3, 0.7%
SAGE
3 publications, 0.7%
Public Library of Science (PLoS)
Public Library of Science (PLoS), 3, 0.7%
Public Library of Science (PLoS)
3 publications, 0.7%
Bioscientifica
Bioscientifica, 3, 0.7%
Bioscientifica
3 publications, 0.7%
Bentham Science
Bentham Science, 2, 0.47%
Bentham Science
2 publications, 0.47%
Impact Journals
Impact Journals, 2, 0.47%
Impact Journals
2 publications, 0.47%
IOS Press
IOS Press, 2, 0.47%
IOS Press
2 publications, 0.47%
S. Karger AG
S. Karger AG, 2, 0.47%
S. Karger AG
2 publications, 0.47%
Wolters Kluwer Health
Wolters Kluwer Health, 2, 0.47%
Wolters Kluwer Health
2 publications, 0.47%
Baishideng Publishing Group
Baishideng Publishing Group, 2, 0.47%
Baishideng Publishing Group
2 publications, 0.47%
American Physiological Society
American Physiological Society, 2, 0.47%
American Physiological Society
2 publications, 0.47%
AME Publishing Company
AME Publishing Company, 2, 0.47%
AME Publishing Company
2 publications, 0.47%
American Society for Clinical Investigation
American Society for Clinical Investigation, 1, 0.23%
American Society for Clinical Investigation
1 publication, 0.23%
The Company of Biologists
The Company of Biologists, 1, 0.23%
The Company of Biologists
1 publication, 0.23%
Pharmaceutical Society of Korea
Pharmaceutical Society of Korea, 1, 0.23%
Pharmaceutical Society of Korea
1 publication, 0.23%
Federation of American Societies for Experimental Biology (FASEB)
Federation of American Societies for Experimental Biology (FASEB), 1, 0.23%
Federation of American Societies for Experimental Biology (FASEB)
1 publication, 0.23%
Dove Medical Press
Dove Medical Press, 1, 0.23%
Dove Medical Press
1 publication, 0.23%
Thieme
Thieme, 1, 0.23%
Thieme
1 publication, 0.23%
10
20
30
40
50
60
70
80
90
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Zhao Y. et al. ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway // Molecular Cancer. 2017. Vol. 16. No. 1. 79
GOST all authors (up to 50) Copy
Zhao Y., HU X., Liu Y., Dong S., Wen Z., He W., Zhang S., Huang Q., Shi M. ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway // Molecular Cancer. 2017. Vol. 16. No. 1. 79
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1186/s12943-017-0648-1
UR - https://doi.org/10.1186%2Fs12943-017-0648-1
TI - ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway
T2 - Molecular Cancer
AU - Zhao, Yang
AU - HU, XINGBIN
AU - Liu, Yajing
AU - Dong, Shumin
AU - Wen, Zhaowei
AU - He, Wanming
AU - Zhang, Shuyi
AU - Huang, Qiong
AU - Shi, Min
PY - 2017
DA - 2017/04/13 00:00:00
PB - Springer Nature
IS - 1
VL - 16
PMID - 28407774
SN - 1476-4598
ER -
BibTex
Cite this
BibTex Copy
@article{2017_Zhao,
author = {Yang Zhao and XINGBIN HU and Yajing Liu and Shumin Dong and Zhaowei Wen and Wanming He and Shuyi Zhang and Qiong Huang and Min Shi},
title = {ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway},
journal = {Molecular Cancer},
year = {2017},
volume = {16},
publisher = {Springer Nature},
month = {apr},
url = {https://doi.org/10.1186%2Fs12943-017-0648-1},
number = {1},
doi = {10.1186/s12943-017-0648-1}
}
Found error?